Glenmede Trust’s Kinetik KNTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$865K Buy
17,865
+2
+0% +$85 ﹤0.01% 790
2025
Q4
$644K Buy
+17,863
New +$645K ﹤0.01% 863
2025
Q1
$736K Sell
14,163
-600
-4% -$35.2K ﹤0.01% 787
2024
Q4
$837K Sell
14,763
-230
-2% -$12.4K ﹤0.01% 777
2024
Q3
$679K Sell
14,993
-1,800
-11% -$77.9K ﹤0.01% 832
2024
Q2
$696K Buy
16,793
+60
+0.4% +$2.38K ﹤0.01% 789
2024
Q1
$667K Buy
16,733
+501
+3% +$17.2K ﹤0.01% 826
2023
Q4
$542K Hold
16,232
﹤0.01% 871
2023
Q3
$548K Hold
16,232
﹤0.01% 819
2023
Q2
$508K Hold
16,232
﹤0.01% 828
2023
Q1
$508K Hold
16,232
﹤0.01% 832
2022
Q4
$537K Buy
16,232
+1,402
+9% +$47.7K ﹤0.01% 819
2022
Q3
$483K Buy
14,830
+1,850
+14% +$68.2K ﹤0.01% 830
2022
Q2
$443K Buy
12,980
+2,160
+20% +$80.1K ﹤0.01% 892
2022
Q1
$351K Buy
+10,820
New +$353K ﹤0.01% 996

Other funds holding KNTK

Glenmede Trust's KNTK Position: Q1 2026 in Review

Glenmede Trust increased its Kinetik (KNTK) stake by 0.01% in Q1 2026, buying an estimated $85 and bringing the position to 17,865 shares worth $865K. The position accounts for ﹤0.01% of the portfolio, ranked #790.

Glenmede Trust first reported a position in KNTK in Q1 2022 and has held it in 15 quarters since. 308 funds tracked by Wall St. Rank hold KNTK as of Q1 2026.

  • Glenmede Trust held 17,865 shares of Kinetik worth $865K as of Q1 2026.
  • Glenmede Trust bought 2 Kinetik shares in Q1 2026, an estimated $85.
  • Kinetik made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #790 holding.
  • Glenmede Trust first reported a position in Kinetik in Q1 2022 and has held it in 15 quarters since.
  • 308 funds tracked by Wall St. Rank held Kinetik as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.